Found: 7
Select item for more details and to access through your institution.
2855. Respiratory Syncytial Virus Neutralizing Antibodies in Cord Blood and Serum from Infants up to 2 Years of Age in a Multinational Prospective Study.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S74, doi. 10.1093/ofid/ofz359.160
- By:
- Publication type:
- Article
A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response.
- Published in:
- Cell Research, 2011, v. 21, n. 6, p. 895, doi. 10.1038/cr.2011.2
- By:
- Publication type:
- Article
Respiratory syncytial virus acute respiratory infections in ≥ 65-year-old adults in long-term care facilities in the Czech Republic.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12–23 Months of Age.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 11, p. 1293, doi. 10.1093/infdis/jiac481
- By:
- Publication type:
- Article
Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article